Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.

about

Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.

Item

http://www.wikidata.org/entity/Q38418522

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Modeling of the pharmacokineti ...... zide in normotensive subjects.

@en

type

Item

label

Modeling of the pharmacokineti ...... zide in normotensive subjects.

@en

prefLabel

Modeling of the pharmacokineti ...... zide in normotensive subjects.

@en

P1476

Modeling of the pharmacokineti ...... zide in normotensive subjects.

@en

P2093

Mohsen A Hedaya

http://www.w3.org/2001/XMLSchema#string

Sally A Helmy

http://www.w3.org/2001/XMLSchema#string

P2860

Drug interactions with angiotensin receptor blockers.

High-affinity interaction of sartans with H+/peptide transporters.

HPLC determination of irbesartan in human plasma: its application to pharmacokinetic studies.

Renal implications of angiotensin receptor blockers.

Drug interactions with irbesartan.

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.

Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.

Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics.

Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorγ-hepatocyte growth factor pathway independent of angiotensin II Type 1a receptor blockade in mouse model of salt-sensitive hypertension

P304

216-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BDD.1935

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25545238

http://www.w3.org/2001/XMLSchema#string

Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.

about

Modeling of the pharmacokinetic/pharmacodynamic interaction between irbesartan and hydrochlorothiazide in normotensive subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698